Phase I trial of docetaxel, cisplatin and concurrent radical radiotherapy in locally advanced oesophageal cancer

BACKGROUND: Locally advanced oesophageal cancer (LAEC) is associated with poor survival and more effective treatments are needed. The aim of this phase I trial was to assess the maximum tolerated dose (MTD) of a novel weekly docetaxel and cisplatin regimen concurrent with radical radiotherapy. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Day, F L, Leong, T, Ngan, S, Thomas, R, Jefford, M, Zalcberg, J R, Rischin, D, McKendick, J, Milner, A D, Di Iulio, J, Matera, A, Michael, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3031899/
https://www.ncbi.nlm.nih.gov/pubmed/21157450
http://dx.doi.org/10.1038/sj.bjc.6606051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3031899/
https://www.ncbi.nlm.nih.gov/pubmed/21157450
http://dx.doi.org/10.1038/sj.bjc.6606051

Ejemplares similares